Barclays PLC Novartis Ag Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Novartis Ag stock. As of the latest transaction made, Barclays PLC holds 1,314 shares of NVS stock, worth $138,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,314

Previous 27,652 95.25%

Holding current value

$138,535

Previous $3.18 Million 95.98%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$96.78 - $117.18 $2.55 Million - $3.09 Million	-26,338 Reduced 95.25%	1,314 $128,000
Q3 2024 Nov 15, 2024	BUY	$106.13 - $120.89 $2.77 Million - $3.16 Million	26,139 Added 1727.63%	27,652 $3.18 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $107,844 - $125,086	1,165 Added 334.77%	1,513 $161,000
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $2,762 - $3,145	29 Added 9.09%	348 $34,000
Q4 2023 Feb 15, 2024	SELL	$92.27 - $101.54 $830 - $913	-9 Reduced 2.74%	319 $32,000
Q3 2023 Nov 07, 2023	SELL	$94.73 - $105.13 $1.01 Million - $1.12 Million	-10,650 Reduced 97.01%	328 $33,000
Q2 2023 Aug 03, 2023	BUY	$92.52 - $104.91 $966,463 - $1.1 Million	10,446 Added 1963.53%	10,978 $1.11 Million
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $56,581 - $65,616	-707 Reduced 57.06%	532 $49,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $2.95 Million - $3.62 Million	-39,091 Reduced 96.93%	1,239 $113,000
Q3 2022 Nov 03, 2022	BUY	$74.61 - $87.26 $2.89 Million - $3.38 Million	38,754 Added 2459.01%	40,330 $3.07 Million
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $93,483 - $108,843	1,161 Added 279.76%	1,576 $133,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $801 - $906	10 Added 2.47%	415 $36,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $8.49 Million - $9.38 Million	-106,478 Reduced 99.62%	405 $35,000
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $4.25 Million - $4.95 Million	51,994 Added 94.73%	106,883 $8.74 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $1.13 Million - $1.25 Million	-13,283 Reduced 19.48%	54,889 $5.01 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $4.51 Million - $5.32 Million	53,993 Added 380.8%	68,172 $5.83 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $8.56 Million - $10.4 Million	-109,662 Reduced 88.55%	14,179 $1.34 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $9.95 Million - $11 Million	121,145 Added 4493.51%	123,841 $10.8 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $3.41 Million - $3.84 Million	-42,122 Reduced 93.98%	2,696 $236,000
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $3.11 Million - $4.36 Million	43,999 Added 5372.28%	44,818 $3.7 Million
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $2.77 Million - $3.13 Million	-32,809 Reduced 97.56%	819 $78,000
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $1.9 Million - $2.09 Million	22,180 Added 193.75%	33,628 $2.92 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $2.3 Million - $2.83 Million	-30,546 Reduced 72.74%	11,448 $1.05 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $1.42 Million - $1.62 Million	18,818 Added 81.2%	41,994 $4.04 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $144,152 - $160,513	-1,957 Reduced 7.79%	23,176 $1.99 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $908,108 - $1.05 Million	13,566 Added 117.28%	25,133 $2.17 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $5,776 - $6,529	-89 Reduced 0.76%	11,567 $874,000
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $762,816 - $911,933	10,837 Added 1323.2%	11,656 $942,000
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $115,728 - $124,224	-1,600 Reduced 66.14%	819 $69,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $179,344 - $186,916	2,419	2,419 $208,000

Others Institutions Holding NVS

# of Institutions

1,462

Shares Held

132M

Call Options Held

1.33M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account